BIM Share Price

Open 67.72 Change Price %
High 68.41 1 Day 0.34 0.50
Low 67.39 1 Week 0.00 0.00
Close 67.68 1 Month -2.86 -4.05
Volume 73747 1 Year -62.27 -47.92
52 Week High 208.85
52 Week Low 66.52
BIM Important Levels
Resistance 2 68.63
Resistance 1 68.24
Pivot 67.83
Support 1 67.12
Support 2 66.73
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
BRS 12.00 0.00%
BRS 12.00 0.00%
More..
EPA France Top Gainers Stocks
MLFCI 0.31 34.78%
AVT 0.19 26.67%
AVT 0.19 26.67%
AVT 0.19 26.67%
AVT 0.19 26.67%
ALFRE 1.81 25.69%
CFI 2.01 20.36%
CFI 2.01 20.36%
CFI 2.01 20.36%
CFI 2.01 20.36%
More..
EPA France Top Losers Stocks
MLROU 6.37 -34.19%
MLLEA 0.61 -23.75%
ALAUP 0.20 -13.04%
OXI 0.08 -11.11%
OXI 0.08 -11.11%
MLFXO 3.79 -9.98%
TONN 1.20 -9.77%
ALCLS 26.88 -9.22%
RUSAL 10.00 -9.09%
ALEUP 0.20 -9.09%
More..

BioMerieux SA (EPA: BIM)

BIM Technical Analysis 5
As on 1st Nov 2017 BIM Share Price closed @ 67.68 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 156.86 & Strong Sell for SHORT-TERM with Stoploss of 125.74 we also expect STOCK to react on Following IMPORTANT LEVELS.
BIM Target for November
1st Target up-side 70.76
2nd Target up-side 72.98
3rd Target up-side 75.21
1st Target down-side 64.4
2nd Target down-side 62.18
3rd Target down-side 59.95
BIM Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.biomerieux.com
BIM Address
BIM
376, chemin de l
Marcy l'Etoile, 69280
France
Phone: 33 4 78 87 20 00
Fax: 33 4 78 87 20 90
BIM Latest News
Interactive Technical Analysis Chart BioMerieux SA ( BIM EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on BioMerieux SA
BIM Business Profile
bioMérieux SA designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company’s diagnostic systems consist of reagents and consumables used to conduct biological tests, for use in performing screening, diagnostic assistance, prognosis, and treatment monitoring; instruments, platforms, or autoanalyzers used for automated testing at high or low throughputs; software to process analyses and systems to interpret the biological test results; and related services, such as the installation and maintenance of instruments, user training, or the audit of laboratory workflows. It offers diagnostic systems for clinical applications, including the diagnosis of infectious diseases, comprising HIV, tuberculosis, and respiratory diseases, as well as cardiovascular diseases and targeted cancers based on the analysis of biological samples, such as blood, saliva, and urine; and for industrial applications, including the analysis of microbiological manufacturing, such as food, pharmaceuticals, and cosmetics. The company markets and sells its products through a network of distributors to private-sector analysis laboratories, hospital laboratories, blood banks, and physician office laboratories; food, pharmaceutical, and cosmetics industries; and independent quality-control laboratories. It has operations in Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. The company was formerly known as B-D Mérieux and changed its name to bioMérieux SA. The company was founded in 1963 and is headquartered in Marcy l’Etoile, France. bioMérieux SA is a subsidiary of Institut Mérieux.